Hematospermia: Should You Be Worried About Bloody Semen?
Hematospermia: Should You Be Worried About Bloody Semen?
The Big Picture
Hematospermia, or bloody semen, is a rare condition often alarming to those who experience it, but it is usually harmless. This article explores the causes, evaluation, and treatment options for hematospermia.
Contents
- What Causes Hematospermia?
- How Is It Evaluated?
- Treatment and Management Strategies
What Causes Hematospermia?
The most common cause of hematospermia is undergoing a prostate biopsy, affecting over 80% of men post-procedure. Other causes include radiation therapy for prostate cancer, vasectomy, and infections like sexually transmitted infections (STIs). In men over 40, genitourinary cancers are considered, though they are rare.
How Is It Evaluated?
A thorough evaluation of hematospermia includes a medical history, physical examination, and urinalysis. Further tests, like transrectal ultrasound, are recommended if the condition persists for over a month. In older men, a more detailed evaluation might be considered due to a slightly higher risk of prostate cancer.
Treatment and Management Strategies
Most cases of hematospermia resolve on their own without specific treatment. Reassurance is crucial, especially if the condition follows a procedure like a prostate biopsy. If an infection or other treatable condition is found, appropriate treatment should be administered.
FAQs
Is hematospermia a sign of cancer?
It is almost never a sign of cancer, especially in younger patients.
How long does hematospermia last after a prostate biopsy?
It typically lasts three to four weeks.
Should all cases of hematospermia be evaluated extensively?
No, extensive evaluation is usually not needed unless symptoms persist.
Can hematospermia resolve on its own?
Yes, most cases resolve spontaneously without treatment.
Are older men at a higher risk of prostate cancer if they have hematospermia?
There is a slightly higher risk in men over 50.
Key Takeaways
While hematospermia can be alarming, it is typically harmless and resolves on its own.
Additional References
- Ahmad I, Krishna NS. Hemospermia. J Urol 2007; 177:1613.
- Raaijmakers R, Kirkels WJ, Roobol MJ, et al. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate. Urology 2002; 60:826.
- Moman MR, van der Heide UA, Kotte AN, et al. Long-term experience with transrectal and transperineal implantations. Radiother Oncol 2010; 96:38.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.